References
- DISA Global Solutions. Map of cannabis legality by state; 2021 [accessed 2021 Jan 20]. https://disa.com/map-of-cannabis-legality-by-state.
- Martins SS, Mauro CM, Santaella-Tenorio J, Kim JH, Cerda M, Keyes KM, Hasin DS, Galea S, Wall M. State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general U.S. population. Drug Alcohol Depend. 2016;169:26–32. doi:https://doi.org/10.1016/j.drugalcdep.2016.10.004.
- Mauro CM, Newswanger P, Santaella-Tenorio J, Mauro PM, Carliner H, Martins SS. Impact of medical cannabis laws on state-level cannabis use by age and gender, 2004-2013. Prev Sci. 2019;20:205–14. doi:https://doi.org/10.1007/s11121-017-0848-3.
- Compton WM, Han B, Hughes A, Jones CM, Blanco C. Use of marijuana for medical purposes among adults in the United States. JAMA. 2017;317:209–11. doi:https://doi.org/10.1001/jama.2016.18900.
- Park JY, Wu LT. Differences in behavioral health disorders and unmet treatment needs between medical marijuana users and recreational marijuana users: results from a national adult sample. Drug Alcohol Depend. 2017;180:311–18. doi:https://doi.org/10.1016/j.drugalcdep.2017.08.028.
- Turna J, Balodis I, Munn C, Van Ameringen M, Busse J, MacKillop J. Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users. Compr Psychiatry. 2020;102:152188. doi:https://doi.org/10.1016/j.comppsych.2020.152188.
- Substance Abuse and Mental Health Services Administration. Reports and detailed tables from the 2019 National Survey on Drug Use and Health (NSDUH); 2020 [accessed 2020 Oct 25]. https://www.samhsa.gov/data/report/2019-nsduh-detailed-tables
- Choi NG, DiNitto DM, Marti CN. Nonmedical versus medical marijuana use among three age groups of adults: associations with mental and physical health status. Am J Addict. 2017;26:697–706. doi:https://doi.org/10.1111/ajad.12598.
- Lin LA, Ilgen MA, Jannausch M, Bohnert KM. Comparing adults who use cannabis medically with those who use recreationally: results from a national sample. Addict Behav. 2016;61:99–103. doi:https://doi.org/10.1016/j.addbeh.2016.05.015.
- Azcarate PM, Zhang AJ, Keyhani S, Steigerwald S, Ishida JH, Cohen BE. Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population. J Gen Intern Med. 2020;35:1979–86. doi:https://doi.org/10.1007/s11606-020-05800-7.
- Fairman BJ. Trends in registered medical marijuana participation across 13 US states and District of Columbia. Drug Alcohol Depend. 2016;159:72–79. doi:https://doi.org/10.1016/j.drugalcdep.2015.11.015.
- Brown JD, Costales B, Van Boemmel-wegmann S, Goodin AJ, Segal R, Winterstein AG. Characteristics of older adults who were early adopters of medical cannabis in the Florida medical cannabis use registry. J Clin Med. 2020;9:1166. doi:https://doi.org/10.3390/jcm9041166.
- Reynolds IR, Fixen DR, Parnes BL, Lum HD, Shanbhag P, Church S, Linnebur SA, Orosz G. Characteristics and patterns of marijuana use in community-dwelling older adults. J Am Geriatr Soc. 2018;66:2167–71. doi:https://doi.org/10.1111/jgs.15507.
- Bobitt J, Qualls SH, Schuchman M, Wickersham R, Lum HD, Arora K, Milavetz G, Kaskie B. Qualitative analysis of cannabis use among older adults in Colorado. Drugs Aging. 2019;36:655–66. doi:https://doi.org/10.1007/s40266-019-00665-w.
- Manning L, Bouchard L. Medical cannabis use: exploring the perceptions and experiences of older adults with chronic conditions. Clin Gerontol. 2020. 1–10. doi:https://doi.org/10.1080/07317115.2020.1853299. [Epub ahead of print].
- Substance abuse & mental health data archives. National Survey on Drug Use and Health. [accessed 2020 Oct 3]. https://www.datafiles.samhsa.gov/study-series/national-survey-drug-use-and-health-nsduh-nid13517.
- Center for Behavioral Health Statistics and Quality. 2019 National survey on drug use and health public use file codebook. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2020.
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994.
- Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991;86:1119–27. doi:https://doi.org/10.1111/j.1360-0443.1991.tb01879.x.
- Furukawa TA, Kessler RC, Slade T, Andrews G. The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-being. Psychol Med. 2003;33:357–62. doi:https://doi.org/10.1017/s0033291702006700.
- Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, Howes MJ, Normand SL, Manderscheid RW, Walters EE, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60:184–89. doi:https://doi.org/10.1001/archpsyc.60.2.184.
- Novak SP, Colpe LJ, Barker PR, Gfroerer JC. Development of a brief mental health impairment scale using a nationally representative sample in the USA. Int J Methods Psychiatr Res. 2010;19:49–60. doi:https://doi.org/10.1002/mpr.313.
- Rehm J, Üstün TB, Saxena S, Nelson CB, Chatterji S, Ivis F, Adlaf E. On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population. Int J Methods Psychiatr Res. 1999;8:110–23. doi:https://doi.org/10.1002/mpr.61.
- Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2020. HHS Publication No. PEP20-07-01-001, NSDUH Series H-55. [accessed 2020 Oct 25]. https://store.samhsa.gov/product/key-substance-use-and-mental-health-indicators-in-the-united-states-results-from-the-2019-national-survey-on-Drug-Use-and-Health/PEP20-07-01-001.
- The United States Census Bureau. How the census bureau measures poverty; 2020 [accessed 2021 Jan 25]. https://www.census.gov/topics/income-poverty/poverty/guidance/poverty-measures.html.
- Allison P. When can you safely ignore multicollinearity? 2012 [accessed 2020 Oct 15]. https://statisticalhorizons.com/multicollinearit.
- Han BH, Palamar JJ. Trends in cannabis use among older adults in the United States, 2015-2018. JAMA Intern Med. 2020 Apr 1;180:609–11. doi:https://doi.org/10.1001/jamainternmed.2019.7517.
- MedCardNow. How to apply for a medical cannabis card online; 2020 [accessed 2020 Dec 20]. https://www.medcardnow.com/learn/how-to-apply-for-a-medical-cannabis-card/.
- Haug NA, Padula CB, Sottile JE, Vandrey R, Heinz AJ, Bonn-Miller MO. Marijuana use patterns and motives: a comparison of younger, middle-aged, and older medical marijuana dispensary patients. Addict Behav. 2017;72:14–20. doi:https://doi.org/10.1016/j.addbeh.2017.03.006.
- Shover CL, Vest NA, Chen D, Stueber A, Falasinnu TO, Hah JM, Kim J, Mackey I, Weber KA 2nd, Ziadni M, et al. Association of state policies allowing medical cannabis for opioid use disorder with dispensary marketing for this indication. JAMA Netw Open. 2020 Jul 1;3:e2010001. doi:https://doi.org/10.1001/jamanetworkopen.2020.10001.
- Blanco C, Hasin DS, Wall MM, Flórez-Salamanca L, Hoertel N, Wang S, Kerridge BT, Olfson M. Cannabis use and risk of psychiatric disorders: prospective evidence from a US national longitudinal study. JAMA Psychiatry. 2016;73:388–95. doi:https://doi.org/10.1001/jamapsychiatry.2015.3229.
- Mammen G, Rueda S, Roerecke M, Bonato S, Lev-Ran S, Rehm J. Association of cannabis with long-term clinical symptoms in anxiety and mood disorders: a systematic review of prospective studies. J Clin Psychiatry. 2018;79:17r11839. doi:https://doi.org/10.4088/JCP.17r11839.
- Bahorik AL, Leibowitz A, Sterling SA, Travis A, Weisner C, Satre DD. Patterns of marijuana use among psychiatry patients with depression and its impact on recovery. J Affect Disord. 2017;213:168–71. doi:https://doi.org/10.1016/j.jad.2017.02.016.
- Bahorik AL, Sterling SA, Campbell CI, Weisner C, Ramo D, Satre DD. Medical and non-medical marijuana use in depression: longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization. J Affect Disord. 2018;241:8–14. doi:https://doi.org/10.1016/j.jad.2018.05.065.
- Han B, Compton WM, Blanco C, Jones CM. Trends in and correlates of medical marijuana use among adults in the United States. Drug Alcohol Depend. 2018;186:120–29. doi:https://doi.org/10.1016/j.drugalcdep.2018.01.022.
- Corroon JM Jr, Mischley LK, Sexton M. Cannabis as a substitute for prescription drugs - a cross-sectional study. J Pain Res. 2017;10:989–98. doi:https://doi.org/10.2147/JPR.S134330.
- Cohen K, Weizman A, Weinstein A. Positive and negative effects of cannabis and cannabinoids on health. Clin Pharmacol Ther. 2019;105:1139–47. doi:https://doi.org/10.1002/cpt.1381.
- ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States. Biol Psychiatry. 2016;79:613–19. doi:https://doi.org/10.1016/j.biopsych.2016.01.004.
- Matheson J, Le Foll B. Cannabis legalization and acute harm from high potency cannabis products: a narrative review and recommendations for public health. Front Psychiatry. 2020;11:591979. doi:https://doi.org/10.3389/fpsyt.2020.591979.
- Woelfl T, Rohleder C, Mueller JK, Lange B, Reuter A, Schmidt AM, Koethe D, Hellmich M, Leweke FM. Effects of cannabidiol and delta-9-tetrahydrocannabinol on emotion, cognition, and attention: a double-blind, placebocontrolled, randomized experimental trial in healthy volunteers. Front Psychiatry. 2020;11:576877. doi:https://doi.org/10.3389/fpsyt.2020.576877.
- National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington (DC): National Academies Press (US); 2017 Jan 12.
- Goodman S, Wadsworth E, Leos-Toro C, Hammond D; International Cannabis Policy Study team. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. Int J Drug Policy. 2020;76:102658. doi:https://doi.org/10.1016/j.drugpo.2019.102658.
- Choi NG, Marti CN, DiNitto DM, Baker SD. Cannabis and synthetic cannabinoid poison control center cases among adults aged 50+, 2009-2019. Clin Toxicol (Phila). 2021;9:334–42. doi:https://doi.org/10.1080/15563650.2020.1806296.